logo
15:59 Feb 25

Bliss GVS Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
219.02
+8.44 (+4.01%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Bliss GVS Pharma Ltd. Financials

Bliss GVS Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
219.02
+8.44 (+4.01%)
15:59 Feb 25
Quality
image/svg+xml

59/100
High Financial Strength

Valuation
image/svg+xml

48/100
Mid Valuation

Technical

62/100
Technically Moderately Bullish

Strength

9

Weakness

4

Opportunity

1

Threats

0

8.02 %

ROE %

6.48 %

ROA %

10.31

EPS

99.68

BVPS

10.41 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
577.21 747.45 751.59 770.24 809.73
Operating Expenses +
470.56 629.12 634.27 619.62 683.04
Raw Material
340.79 420.18 374.38 390.47 421.79
Increase Decrease in Cost
-11.88 -29.2 26.94 -8.35 -8.11
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
68.09 76.15 86.17 95.58 112.05
Miscellaneous Expenses
235.52 231.81 235.46 244.62 255.87
Operating Profit
106.65 118.33 117.32 150.62 126.69
Other Income
20.22 31.49 17.79 28.74 36.49
Depreciation
17.23 17.33 18.67 26.38 29.42
Interest
5.51 4.74 10.36 6.91 8.12
Profit before tax and exceptio..
104.13 127.76 106.07 146.07 125.64
Exceptional Items
0 -73.59 0 -29.2 0
PBT
104.13 54.17 106.07 116.87 125.64
Provision for Taxation
30.16 31.04 29.34 35.29 35.38
Net Profit
73.97 23.13 76.73 81.58 90.26
NET Profit after MI
68.49 15.04 70.86 75.45 84.3
EPS
6.64 1.46 6.72 7.23 7.95
Operating Profit Margin (%)
18.48 15.83 15.61 19.55 15.65
Net Profit Margin (%)
11.87 2.01 9.43 9.8 10.41

Bliss GVS Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 35.40 35.40 35.40 35.30 35.10 34.80
FII 14.50 13.30 12.60 13.20 13.50 12.10
Public 5.80 5.90 6.60 6.50 6.60 6.60
Others 44.30 45.40 45.40 45.00 44.80 46.50
Shareholder Shares Holding %
Research 360 logo
Download Our App On: